- Home
- APGE vs CAKE Comparison
APGE vs CAKE Comparison
Compare APGE & CAKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- CAKE
- Stock Information
- Founded
- APGE 2022
- CAKE 1972
- Country
- APGE United States
- CAKE United States
- Employees
- APGE N/A
- CAKE N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- CAKE Restaurants
- Sector
- APGE Health Care
- CAKE Consumer Discretionary
- Exchange
- APGE Nasdaq
- CAKE Nasdaq
- Market Cap
- APGE 3.0B
- CAKE 2.5B
- IPO Year
- APGE 2023
- CAKE 1992
- Fundamental
- Price
- APGE $48.46
- CAKE $49.62
- Analyst Decision
- APGE Strong Buy
- CAKE Hold
- Analyst Count
- APGE 6
- CAKE 16
- Target Price
- APGE $75.40
- CAKE $47.33
- AVG Volume (30 Days)
- APGE 588.6K
- CAKE 1.0M
- Earning Date
- APGE 11-12-2024
- CAKE 10-29-2024
- Dividend Yield
- APGE N/A
- CAKE 2.15%
- EPS Growth
- APGE N/A
- CAKE 52.49
- EPS
- APGE N/A
- CAKE 2.64
- Revenue
- APGE N/A
- CAKE $3,537,745,000.00
- Revenue This Year
- APGE N/A
- CAKE $5.97
- Revenue Next Year
- APGE N/A
- CAKE $5.40
- P/E Ratio
- APGE N/A
- CAKE $19.47
- Revenue Growth
- APGE N/A
- CAKE 2.39
- 52 Week Low
- APGE $22.20
- CAKE $31.24
- 52 Week High
- APGE $72.29
- CAKE $52.10
- Technical
- Relative Strength Index (RSI)
- APGE 47.85
- CAKE 55.02
- Support Level
- APGE $41.85
- CAKE $49.33
- Resistance Level
- APGE $48.27
- CAKE $51.80
- Average True Range (ATR)
- APGE 3.56
- CAKE 1.54
- MACD
- APGE 0.31
- CAKE -0.19
- Stochastic Oscillator
- APGE 47.51
- CAKE 41.19
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.
About CAKE Cheesecake Factory Incorporated (The)
Cheesecake Factory Inc owns and operates restaurants in the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.